← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Monobactams
carumonam
J01DF02
Forms & Strengths
- lyophilized powder for injection 1000mg
- lyophilized powder for injection 500mg
Adult Dosing
- 500-1000mg IV q8h for UTI
- 1000mg IV q8h for pneumonia
- 500-1000mg IV q8h for skin infections
Pediatric Dosing
- 6-12 years: 250-500mg IV q8h
- 1-5 years: 125-250mg IV q8h
- less than 1 year: not recommended
Indications
- complicated urinary tract infections
- lower respiratory tract infections
- skin and soft tissue infections
Mechanism of Action
- inhibits bacterial cell wall synthesis
- binds to penicillin-binding proteins
- exerts bacteriocidal effects
Contraindications
- hypersensitivity to carumonam or other monobactams
- hypersensitivity to cephalosporins
- pregnancy and lactation
Adverse Reactions
- diarrhea
- nausea and vomiting
- rash and itching
- elevated liver enzymes
Drug Interactions
- increased nephrotoxicity with aminoglycosides
- increased risk of bleeding with anticoagulants
- decreased efficacy with tetracyclines
Curated Content: Needs Vetting Before Put to Clinical Use